CathRX, Mesoblast, ChemGenex, Living Cell Technologies, QRxPharma, CSL, ResMed, Cochlear [ + ]

Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target. [ + ]

Lilly to use Starpharma's dendrimer drug delivery technology for human pharmaceuticals. [ + ]

Indium phosphide, di-tert-butyl peroxide and trixylyl phosphate have been looked at by the Committee for Risk Assessment (RAC) of ECHA (European Chemicals Agency in Helsinki).

Nine Australia Fellowships, worth $36 million in total, have been awarded by the NHMRC. [ + ]

UPDATED: Thermo Fisher Scientific goes direct with range of product lines. [ + ]

Collaboration between Patrys and CSL sends Patrys stocks soaring. [ + ]

Dr Owen Maroney claims we can remember in a reversed universe and it's all to do with the heat coming from your computer.

Matthew Lehman new chief operating officer for Prima BioMed will help commercialise CVac. [ + ]

The sale of Applied Biosystems' mass spectrometry business to Danaher Corporation will result in the formation of a new Danaher operating company, known as AB Sciex.

Mesoblast, Sirtex, Prima BioMed, pSivida, Cochlear, Living Cell Technology [ + ]

Licensing deal for natural insecticide, Qcide, assigned to Bio-Gene Technology. [ + ]

Australian universities will receive federal funding for research and research training totalling $1.42 billion in 2010.

Queensland biotechnology companies are set to receive an increased visibility with overseas investors, following the signing of a partnership between a United States venture capital group and a group of leading Queensland life sciences entities.

Living Cell Technologies has been granted a European patent for the use of its product NTCELL in the treatment of degenerative neurological conditions. [ + ]